Preclinical evaluation of biomarkers for ovarian cancer detection and monitoring for disease recurrence

被引:0
|
作者
Havrilesky, Laura J.
Whitehead, Clark
Rubatt, Jennifer
Cheek, Robert L.
Groelke, John
He, Qin
Malinowski, Douglas P.
Fischer, Timothy J.
Berchuck, Andrew
机构
[1] Duke Univ, Durham, NC USA
[2] TriPath Oncol Inc, Durham, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S12 / S12
页数:1
相关论文
共 50 条
  • [1] Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
    Havrilesky, Laura J.
    Whitehead, Clark M.
    Rubatt, Jennifer M.
    Cheek, Robert L.
    Groelke, John
    He, Qin
    Malinowski, Douglas P.
    Fischer, Timothy J.
    Berchuck, Andrew
    GYNECOLOGIC ONCOLOGY, 2008, 110 (03) : 374 - 382
  • [2] Role of biomarkers for early detection of ovarian cancer recurrence
    Giampaolino, Pierluigi
    Foreste, Virginia
    Della Corte, Luigi
    Di Filippo, Claudia
    Iorio, Giuseppe
    Bifulco, Giuseppe
    GLAND SURGERY, 2020, 9 (04) : 1102 - 1111
  • [3] PRECLINICAL DETECTION OF OVARIAN CANCER
    GRAHAM, JB
    GRAHAM, RM
    SCHUELLE.EF
    CANCER, 1964, 17 (11) : 1414 - &
  • [4] Circulating tumor DNA-based detection of molecular residual disease as a biomarker for recurrence monitoring predict disease recurrence in patients with ovarian cancer.
    Lv, Tianjiao
    Shi, Xinyi
    Zhao, Dan
    Sun, Jing
    Wang, Bo
    Lu, Kai
    Zou, ShiPing
    Wang, Jing
    Wang, Qiang
    Feng, Weiwei
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer
    Hou, June Y.
    Chapman, Jocelyn S.
    Kalashnikova, Ekaterina
    Pierson, William
    Smith-McCune, Karen
    Pineda, Geovanni
    Vattakalam, Reena Marie
    Ross, Alexandra
    Mills, Meredith
    Suarez, Carlos J.
    Davis, Tracy
    Edwards, Robert
    Boisen, Michelle
    Sawyer, Sarah
    Wu, Hsin-Ta
    Dashner, Scott
    Aushev, Vasily N.
    George, Giby, V
    Malhotra, Meenakshi
    Zimmermann, Bernhard
    Sethi, Himanshu
    ElNaggar, Adam C.
    Aleshin, Alexey
    Ford, James M.
    GYNECOLOGIC ONCOLOGY, 2022, 167 (02) : 334 - 341
  • [6] Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer
    Kong, FB
    White, CN
    Xiao, XY
    Feng, YJ
    Xu, CJ
    He, DC
    Zhang, Z
    Yu, YH
    GYNECOLOGIC ONCOLOGY, 2006, 100 (02) : 247 - 253
  • [7] Tumor autoantibodies as biomarkers for predicting ovarian cancer recurrence
    Chatterjee, Madhumita
    Dyson, Greg
    Levin, Nancy K.
    Shah, Jay P.
    Morris, Robert
    Munkarah, Adnan
    Tainsky, Michael A.
    CANCER BIOMARKERS, 2012, 11 (2-3) : 59 - 73
  • [8] Biomarkers for early detection of ovarian cancer
    Nguyen, Long
    Cardenas-Goicoechea, Segundo Joel
    Gordon, Pierre
    Curtin, Christina
    Momeni, Mazdak
    Chuang, Linus
    Fishman, David
    WOMENS HEALTH, 2013, 9 (02) : 171 - 187
  • [9] Early Detection Biomarkers for Ovarian Cancer
    Sarojini, Sreeja
    Tamir, Ayala
    Lim, Heejin
    Li, Shihong
    Zhang, Shifang
    Goy, Andre
    Pecora, Andrew
    Suh, K. Stephen
    JOURNAL OF ONCOLOGY, 2012, 2012
  • [10] Biomarkers for ovarian cancer detection and therapy
    Dutta, Sonia
    Wang, Feng-qiang
    Phalen, Adrien
    Fishman, David A.
    CANCER BIOLOGY & THERAPY, 2010, 9 (09) : 668 - 677